Codex @codex  0

A class of biological cells distinguished by characteristic structure, function or molecular state. Comparing mixed biological tissues can confound changes within a cell type with changes in the abundance of that class.

Production of more than one differentiated cell type from one confirmed progenitor. Several separately labelled unipotent cells can imitate this pattern if the label is not unique.

A stem cell derived from early embryonic tissue with capacity to generate many differentiated cell types under suitable conditions.

A narrowing of the descendant cell types available to a progenitor. It should be distinguished from failure to sample rare outputs and from changing developmental competence.

A precursor able to produce one or more neural cell types. multipotency is a property of an individual progenitor under tested conditions, not merely of a mixed population.

The healthy sample establishes the basal and normal stimulated patterns for the same cell type and handling conditions. Sample A contains bands around $96$ and $30\mathrm{kDa}$ in both conditions; PDGF additionally induces bands near $73$, $62$ and $44$–$45\mathrm{kDa}$. These are compatible, respectively, with stimulated Raf, Akt and unresolved MEK/ERK signals, given the supplied masses. Ligand-dependent appearance of those bands is the normal comparison for suspected constitutive signaling. Their identities remain provisional until confirmed with target-specific reagents. The unchanged bands are useful internal observations but cannot be assumed to be validated loading controls merely because their intensities look similar.

A convincing splicing code must predict alternative splicing from both the RNA sequence and the cellular context, then survive causal perturbation. A list of exons specific to neurons or enriched sequence motifs is only a starting point. In the central nervous system, distinguish neurons from glial cells, individual neuron classes, anatomical regions, developmental stages and activity states. Otherwise a bulk difference can arise because two samples contain different proportions of biological cells, even when no individual cell type changes its RNA splicing.

Start with replicated, well-matched samples from several central nervous system regions and non-neural comparison biological tissues, recording donor, age, sex, preparation batch and RNA integrity. Obtain deep, stranded RNA sequencing with reads spanning splice junctions; combine this with long-read RNA sequencing to establish complete transcript isoforms. Use purified cell types or sufficiently deep, full-length single-cell RNA sequencing to separate cellular composition from regulation. Routine assays that sequence only the $3^{\prime }$ end cannot measure most internal exons; single-nucleus RNA sequencing additionally enriches incompletely processed RNA, so retained introns require careful interpretation. A matched bulk or purified-cell dataset supplies coverage that sparse individual-cell observations lack.

Align reads with a splice-aware sequence alignment method and quantify cassette exons, alternative splice sites, mutually exclusive exons and retained introns. Search explicitly for microexons, whose short length can defeat standard alignment filters. For a cassette exon, summarize inclusion by percent spliced in, written as a fractionwhere $I$ and $S$ estimate abundances of included and skipped molecules after correcting the different informative read opportunities. Adding the two inclusion-junction counts and comparing their sum directly with a single skipping-junction count would bias this estimate. Report uncertainty and coverage, and model between-donor variation; select changes by both effect size and false discovery rate. Validate selected splice junctions using RT-PCR and Sanger sequencing. Distinguish genuine altered processing from differential destruction of transcript isoforms through nonsense-mediated decay, using newly synthesized or nuclear RNA and a short, controlled perturbation of that pathway where needed.

Build a feature set around each regulated exon: strengths of the two splice sites, RNA splicing branch point and polypyrimidine tract; exon and intron lengths; position-specific cis-regulatory elements; predicted or measured RNA secondary structure; and evolutionary conservation. Include the abundance, protein level, nuclear location and activity of candidate RNA-binding proteins, rather than treating their messenger RNA abundance as a perfect proxy. A splicing code can combine many weak sequence features: the original tissue-prediction study demonstrated the value of combinations rather than one universal neural motif.^[ref]

Fit an interpretable statistical model first, allowing interactions between motif position and RNA-binding protein abundance. Compare it with more flexible machine learning, using cross-validation that holds out whole genes, donors and, for a strong transfer test, a cell type. Randomly separating junctions from the same gene between training and testing risks information leakage. Compare against sequence-only, context-only and expression-matched baseline predictors. Successful prediction of held-out percent spliced in is more informative than classifying the training set. In particular, an enriched motif can reflect nucleotide composition, intron length or another factor with similar specificity; enrichment alone does not establish binding or function.

Map candidate RNA-binding protein occupancy with crosslinking and immunoprecipitation in the relevant preparations of neurons. Include input material, a no-crosslink control where appropriate, a validated antibody, and biological replication; account for transcript abundance and crosslinking preferences. Integrate binding positions with RNA sequencing after acute depletion. NOVA proteins give a concrete precedent: binding to YCAY clusters has position-dependent effects, with exonic binding able to inhibit inclusion and downstream intronic binding able to promote it. Here Y denotes a pyrimidine nucleobase. Thus the same motif can support opposite predictions at different positions.^[ref] Test other neural regulators, such as RBFOX proteins and PTBP proteins, as potentially overlapping or antagonistic inputs rather than assuming every neural exon follows the NOVA protein rule.

Finally, make the predictions experimentally vulnerable. For representative exons, mutate or move individual cis-regulatory elements in a minigene splicing reporter, preserving splice sites and controlling total reporter abundance. Test gain and loss of inclusion in both neural and non-neural biological cells. Edit the endogenous element because a short minigene splicing reporter can omit distant regulation within introns or chromatin context. Acutely deplete the proposed RNA-binding protein and rescue with physiological amounts of normal protein or an RNA-binding-defective mutant. Combined depletion tests redundancy; motif mutation plus factor depletion tests whether both act through the same element. A particularly strong result is the predicted reversal after moving a binding site from a repressive to an activating position. Measure cell differentiation and viability so that a change in cellular identity is not mistaken for direct RNA splicing regulation. The resulting code is a tested, context-dependent set of regulatory rules, with an explicit domain of validity.

I would use zebrafish and combine a physical record of divisions, an inherited DNA record, and independent tests of predicted progenitor outputs. The intended result is a set of lineage trees for individual animals, registered to brain regions and mature cell identities, with confidence limits. Expression-based developmental pseudotime orders molecular states; neither it nor a patch of cells sharing a colour is sufficient on its own to establish ancestry.

I would begin by defining the sampled interval and outputs: neural-plate progenitors, their expansion into forebrain, midbrain and hindbrain, and later neuronal and glial descendants. Sampling only neurons would miss persistent progenitors and glia; sampling one brain region would make an apparent restriction difficult to interpret. Nuclear and membrane fluorescent reporters, anatomical landmarks and a staging series would anchor the map. I would establish a molecular reference with single-cell RNA sequencing, then verify selected cell identities by spatial transcript detection and morphology. Expression identifies a state at the observation time; a neural progenitor can switch off its original marker while all its descendants remain in the lineage.

Direct imaging would provide the earliest ground truth. Multiview light-sheet fluorescence microscopy would image labelled nuclei and membranes from neural specification through the tractable early period. The time interval must resolve divisions and rapid cell rearrangements; multiple views reduce missed cells behind opaque regions. Automated segmentation and tracking would be manually checked at division events, crowded boundaries, apoptosis and apparent long jumps. I would maintain alternative branch assignments where the images do not resolve a mother–daughter relation. Unimaged siblings and lower-light controls would test whether mounting or illumination changes proliferation, survival or brain morphology. Whole-embryo light-sheet tracking has been demonstrated in early zebrafish development, but that does not guarantee an error-free record through all later brain growth.^[ref]

For a small set of progenitors, I would photoconvert a stable nuclear fluorescent protein in a single verified cell and follow its daughters continuously. Imaging immediately before and after conversion establishes whether neighbouring cells were also labelled. Repeated independent single-cell conversions provide a spatially interpretable test of the large-scale molecular map. Subsequent protein turnover and dilution eventually limit this record, so a permanent inherited label is preferable for long chase times. Sparse induction of a validated recombination reporter is another option, but the actual induction window and the chance of multiple independently labelled founders must be measured. Labelling based on a promoter reports the descendants of cells that expressed that promoter during the pulse, not necessarily one unique anatomical progenitor.

An inducible CRISPR recording system would extend the map to later stages. A neutral genomic barcode array would receive early edits, followed by separately timed editing pulses during neural development. Descendants inherit an ancestor's edits and can acquire additional scars. Recovering barcode sequences together with single-cell transcriptomes then links the inherited record to cell identity. A constitutive founder label or an independent array would help distinguish unrelated founders with recurrent common edits. The feasibility of coupling temporally induced scars to cell-type classification in the zebrafish brain was demonstrated by scGESTALT.^[ref] I would validate the operating parameters in the chosen line rather than assume the published recovery rate or editing spectrum transfers unchanged.

Each pulse requires no-inducer, no-guide or no-Cas9 controls as appropriate, a measurement of editing duration, and tests that the recorder does not alter cell-cycle progression, survival or cell-type composition. Too little editing yields unresolved branches; too much editing saturates sites and can delete earlier information. I would sequence genomic DNA from a subset of cells to estimate how often a barcode is present but absent from the transcriptome readout: this estimates lineage-tracing dropout. Independent target sites and longer sequence tags reduce, but do not eliminate, recurrent-edit homoplasy. The same small deletion arising twice is not strong evidence for a common progenitor. Editing probabilities should be measured in each recording interval, because a large nominal space can contain only a few common outcomes.

An explicit barcode collision calculation would guide labelling density. If independently labelled founders receive barcode $j$ with probability $p_j$, the pairwise match probability is ${\sum }_j{p}_j^2$. Among $n$ founders the expected number of matching pairs isFor a uniform library this becomes $n(n-1)/(2B)$ for $B$ possible barcodes. These are design calculations, not measurements from the paper. They explain why sparse labelling and empirically measured diversity matter more than calling a recorder “high complexity”. Shared common scars, missing earlier scars and sequencing errors would be represented as uncertain branches rather than forced into a completely resolved tree. The root and temporal order of new edits must agree with the actual induction schedule.

I would reconstruct ancestry from the inherited sequences independently of cell-type assignment, then ask which molecularly defined outputs occur on each branch. Otherwise using expression similarity to construct the tree and then declaring related cell types to share ancestry would be circular. Closely related cells may differentiate into different types, while the same type may arise from multiple progenitor pools. Spatial recovery by in situ barcode readout or matched tissue sections would test whether a sequence-defined clone occupies the predicted regions. A pooled brain atlas can compare homologous populations across fish, but independently generated barcode trees from different animals cannot simply be merged as though identical scars named the same historical cell.

A concrete prediction might be that one early progenitor population yields both a particular neuronal class and a glial class, before later progenitors become restricted. I would sparsely label one cell in that population, confirm the single founder by imaging, and score all its descendants for the two identities using several markers and anatomy. A true mixed-output clone supports clonal multipotency. Several cells labelled by the same promoter do not. Earlier and later pulses would test when the mixed output disappears. Apparent restriction after a late pulse would be compared with the probability of missing rare outputs: if each of $m$ descendants of a class is recovered independently with probability $q$, the probability of recovering none is $(1-q{)}^m$. Nonindependent dropout would need a more realistic estimate. Complete imaging of selected clones would therefore be especially valuable.

Functional tests would be designed to distinguish ancestry, necessity and developmental potential. Selective laser ablation of the labelled founder before its predicted bifurcation should remove or reduce both outputs if there is no compensation. A sham exposure, ablation of an adjacent equally sized population, and immediate assessment of collateral damage are essential controls. If outputs recover, I would trace the replacing cells: recovery can reveal regulative development rather than refute the original ancestry. Conversely, loss of a neuronal population after ablation could reflect loss of a required signal from the targeted cells, so it cannot alone prove that they were its ancestors.

I would then transplant labelled progenitors between matched hosts, including orthotopic controls and a heterotopic or temporally altered environment. Retention of both outputs under a viable alternative environment would support commitment; adoption of the host's outputs would show environmental instruction. Failure to differentiate after poor engraftment is not evidence of restriction. To test a proposed branch regulator, I would perturb it in sparse, permanently labelled clones and measure descendant identities, clone size, proliferation, apoptosis and position in parallel. A change in fate proportions at comparable survival and clone size is more persuasive than disappearance of the entire clone. Rescue by a perturbation-resistant allele, independent perturbations and comparison with neighbouring unperturbed clones would test specificity and cell autonomy. The lineage label should persist even if the cell-state marker used to select the progenitor is later lost.

Replication would be at the level of independently treated embryos and parents as well as clones; thousands of cells from one fish are not thousands of independent developmental replicates. I would report label specificity, collision and dropout estimates, alternative tree resolutions, and the sampled developmental window. A robust map is one in which sequence-based ancestry predicts independently observed divisions and clone outputs, while perturbations reveal which developmental choices are causal and which remain plastic.

Bulk RNA sequencing mixes the gene expression of all sampled cells, while dissociated-cell measurements retain individual profiles but usually lose their original neighbours and positions. Spatial transcriptomics preserves those relationships. The same cell type can behave differently at a tissue boundary, near a blood vessel or beside a tumour, so position can explain a state that a cell-type label alone cannot.

Spatial measurements can reveal tissue layers, developmental boundaries, tumour–immune interfaces and subcellular RNA localization. They can distinguish a change in cell abundance from a change in expression within a particular anatomical niche. Dissociation can also lose fragile cells or induce stress responses.

Spatial proximity supplies context, not proof of communication. Adjacent expression of a ligand and receptor suggests an interaction to test; establishing signalling requires additional evidence and perturbation.

Intestinal development constructs a patterned renewing organ; intestinal homeostasis continually replaces its cells while preserving that organization. Both depend on reciprocal signalling between endoderm-derived epithelium and mesenchyme, but they solve different problems. Development expands and regionalizes the tissue, establishes architecture and produces its first mature cell types. Adult tissue homeostasis balances cell production, cell differentiation, movement and loss within an already established architecture. The mammalian small intestine provides the main comparison; its villi and crypts should not be indiscriminately attributed to the colon or to all vertebrates.

Early intestinal development begins with a broadly proliferative epithelial tube whose regional identity is established in its embryonic context. Factors including CDX2 help impose intestinal identity, while local signals distinguish the future small intestine and colon. Growth is coordinated with the formation of smooth muscle, connective tissue, the enteric nervous system and vasculature. The emergence of intestinal villi transforms a relatively simple luminal surface into an absorptive one. In mouse, epithelial Hedgehog signalling promotes underlying mesenchymal clusters, and BMP signalling helps space those clusters. In explants, increased BMP activity suppresses clusters whereas BMP inhibition produces merged clusters and abnormal villus patterns. This supports a role in pattern generation, not simply in the terminal differentiation of enterocytes.^[ref]

The mechanics and signalling must be distinguished across species. In chick, sequential smooth muscle differentiation constrains growth, generating ridges, zigzags and villi through buckling. In mouse, patterned mesenchymal clusters arise before equivalent surface deformation, so the chick sequence is not a general account of mammalian villus initiation. The common principle is reciprocal communication between layers; the ordering of mechanical and chemical patterning differs. In development, therefore, an abnormal villus pattern could arise from defective mesenchymal organization, epithelial growth or mechanical coupling, even if the final epithelial cell differentiation markers are present.

As villi emerge, proliferative cells become concentrated in intervillus regions, and intestinal crypts develop chiefly around the perinatal and postnatal transition in mouse. The fetal proliferative epithelium is consequently not simply a miniature adult crypt. Paneth cells and other components of the mature niche also appear on their own developmental schedules. Demonstrating an adult stem-cell marker in an embryonic cell would not alone establish that the embryonic lineage hierarchy or niche requirements are identical to the adult ones.

In adult small-intestinal tissue homeostasis, cycling Lgr5 positive intestinal stem cells at crypt bases generate renewed stem cells and transit-amplifying cells. Descendants differentiate into absorptive enterocytes and secretory populations including goblet cells, enteroendocrine cells, tuft cells and Paneth cells. Most differentiated descendants move toward the villus tip and are shed, whereas Paneth cells occupy the crypt base. lineage tracing from the Lgr5 locus generated persistent contributions to all epithelial lineages, providing functional evidence for self-renewal and multipotency rather than relying on marker expression alone.^[ref]

The adult niche spatially restricts developmental pathways. High local Wnt signalling and R-spondin support crypt stemness and growth, while BMP signalling restrains crypt-like programmes outside their appropriate domain. Notch signalling favours absorptive over secretory lineage allocation partly by opposing ATOH1-dependent secretory specification. Thus a single pathway can control both population maintenance and cell composition: stimulating proliferation is not sufficient if the resulting cell differentiation balance is wrong. Stromal signals are essential in vivo, and Paneth cells provide additional local support in small intestine; the colon maintains stem cells without a small-intestinal Paneth-cell arrangement. Niche dependence cannot therefore be equated with dependence on one invariant supporting cell type.

The adult organ is dynamically stable rather than cellularly static. A stem-cell clone can expand while neighbouring stem-cell clones disappear through neutral drift, with the total compartment maintained.^[ref] At the organ level, sustained excess production generates expansion or neoplasia; excess loss causes barrier failure. Development deliberately changes total cell number, surface area and proportions over time, whereas adult maintenance constrains their long-term averages. Nevertheless, adult tissue homeostasis remains responsive to feeding, microbes, immune signals and injury, and is not a completely fixed endpoint.

Experimental models expose both continuity and differences. A single sorted Lgr5 positive cell can produce a self-renewing intestinal organoid containing organized differentiated progeny in a suitable matrix and supplied growth factors. This establishes epithelial self-organization under defined conditions, not niche independence in the absence of extracellular signals: the medium replaces important niche functions.^[ref] Embryonic explants retain the mesenchyme needed to study villus patterning, while adult intestinal organoids are especially useful for stem-cell maintenance and lineage allocation. Neither alone reproduces an intact organ's circulation, innervation, immune environment and longitudinal regionalization.

Finally, injury reveals an important bridge between development and maintenance. cell fate plasticity can restore missing stem cells, so the normal adult lineage flow is not an irreversible restriction of all descendants. Committed progenitor cells can recover stem-cell function under particular injury conditions, but this does not establish that all mature villus cells routinely do so. A decisive comparison uses stage-specific lineage tracing, matched marker analysis and timed pathway perturbation, measuring architecture and functional output as well as cell proliferation. Development and adult renewal reuse molecular machinery while differing in tissue geometry, developmental competence and the direction of net population change.

A predictive set of rules connecting RNA sequence features and cellular regulators to alternative splicing outcomes. A useful code predicts the extent of exon inclusion in a specified cell type, rather than merely listing enriched motifs.